7:45-8:00 | Self-guided orientation to online platform | ||
8:00-8:30 | Welcome Michael Tibollo, Associate Minister, Mental Health and Addictions, Ministry of Health Kate Hardy, Network Director, META:PHI Meldon Kahan, Medical Director, META:PHI |
||
8:30-9:30 | Plenary Incorporating anti-oppression praxis in your work with people who use drugs Roberta K. Timothy BA MA MEd PhD |
||
9:30-10:30 | Session 1A Methadone treatment in the fentanyl era: New consensus guidelines Meldon Kahan MD CCFP FRCPC Lori Regenstreif MD CCFP (AM) FCFP MScCH (AMH) CISAM |
Session 1B Resources and strategies to support vulnerable and marginalized patients in RAAM clinics Christina Henry RN BA BScN |
Session 1C Caring for health professionals with SUD Adam Newman MD FCFP (AM) CCSAM Lisa Lefebvre MDCM MPH CCFP (AM) DABAM FASAM CCSAM CMRO Mark Weiss MD MCFP (AM) |
10:30-10:45 | Break | ||
10:45-11:45 | Session 2A Co-prescribing for concurrent disorders Valerie Primeau MD FRCPC |
Session 2B RAAM innovations (1) The Alex RAAM Jennifer Eyford MSc BSc BN RN (2) Lakeridge opioid navigator Lindsay Reynolds MEd RP |
Session 2C Harm reduction for hospitalized patients and people who inject drugs Tali Cahill BScN RN Christopher Francoeur, Community Worker, Oasis Program, Sandy Hill Community Health Centre |
11:45-12:30 | Lunch | ||
12:30-2:00 | Panel Innovations in care for people with SUDs during COVID: What can we learn going forward? Moderator: Vincent Lam MD CCFP (AM) ASAM CSAM (1) Working with managed alcohol/managed stimulant programs during COVID – Michelle Klaiman MD FRCPC DABAM (2) Virtual care – Michael Roach, Regional Lead, Addictions Services, Mental Health and Addictions Programs, Health Sciences North (3) COVID-OAT changes – Tara Gomes PhD MHSc (4) Patient perspective – Malcolm Kennedy |
||
2:00-2:45 | Session 3A Long-acting buprenorphine options Katie Dunham BSc BScN MN NP-PHC Ken Lee MD MCFP (AM) |
Session 3B The role of peer support and lived experience in addiction medicine Josh Richardson RP RPN Psych Cert BA Hons Charles Coke, Peer Support Advocate |
Session 3C MI and brief interventions in the addictions setting Julie Henderson MD FRCPC DABAM Leslie Molnar MSW RSW |
2:45-3:00 | Break | ||
3:00-3:45 | Session 4A Case discussions: RAAM challenges and opportunities Jennifer Wyman MD CCFP FCFP DABAM MPH |
Session 4B Family-centred care Angie Hamilton LLB BCL Louise Lemieux White BScN RN |
Session 4C Contingency management Melissa Holowaty PhD MD CCFP (AM) |
3:45-4:00 | Regroup and wrap-up |
4:00-5:00 (optional) |
Networking A Inpatient medicine Lisa Bromley MD CCFP (AM) FCFP |
Networking B Counsellors and case managers Josh Richardson RP RPN Psych Cert BA Hons |
Networking C Rural and remote practices Tara Leary MD CCFP FCFP |
Networking D Legal/human rights issues and SUD Angie Hamilton LLB BCL Daphne Jarvis LLBN |
Networking E Fentanyl challenges Meldon Kahan MD CCFP FRCPC |
Accreditation
This conference has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up to 6.0 Mainpro+ credits and up to 6.0 Royal College of Physicians and Surgeons of Canada Section 1 hours.
Thank you to our conference planning committee for their input and expertise in the planning of this event:
Leslie Buckley MD MPH FRCPC
Katie Dunham BSc Hons, BScN, MN, NP-PHC
Kate Hardy MSW RSW
Christina Henry RN BScN BA
Elizabeth Shouldice MD CCFP(EM) FCFP MPH
Jennifer Wyman MD CCFP FCFP DABAM MPH
Maria Zhang BScPhrm, PhmD
Session 1A Methadone treatment in the fentanyl era: New consensus guidelines Meldon Kahan MD CCFP FRCPC Lori Regenstreif MD CCFP (AM) FCFP MScCH (AMH) CISAM |
Session 1B Resources and strategies to support vulnerable and marginalized patients in RAAM clinics Christina Henry RN BA BScN |
Session 1C Caring for health professionals with SUD Adam Newman MD FCFP (AM) CCSAM Lisa Lefebvre MDCM MPH CCFP (AM) DABAM FASAM CCSAM CMRO Mark Weiss MD MCFP (AM) |
Session 2A Co-prescribing for concurrent disorders Valerie Primeau MD FRCPC |
Session 2B RAAM innovations (1) Lakeridge opioid navigator: Lindsay Reynolds MEd RP (2) The Alex RAAM: Jennifer Eyford MSc BSc BN RN |
Session 2C Harm reduction for hospitalized patients and people who inject drugs Tali Cahill BScN RN Christopher Francoeur, Community Worker, Oasis Program, Sandy Hill Community Health Centre |
Panel Innovations in care for people with SUDs during COVID: What can we learn going forward? Moderator: Vincent Lam MD CCFP (AM) ASAM CSAM (1) Working with managed alcohol/managed stimulant programs during COVID – Michelle Klaiman MD FRCPC DABAM (2) Virtual care – Michael Roach, Regional Lead, Addictions Services, Mental Health and Addictions Programs, Health Sciences North (3) COVID-OAT changes – Tara Gomes PhD MHSc (4) Patient perspective – Malcolm Kennedy |
||
Session 3A Long-acting buprenorphine options Katie Dunham BSc BScN MN NP-PHC Ken Lee MD MCFP (AM) |
Session 3B The role of peer support and lived experience in addiction medicine Josh Richardson RP RPN Psych Cert BA Hons Charles Coke, Peer Support Advocate |
Session 3C MI and brief interventions in the addictions setting Julie Henderson MD FRCPC DABAM Leslie Molnar MSW RSW |
Session 4A Case discussions: RAAM challenges and opportunities Jennifer Wyman MD CCFP FCFP DABAM MPH |
Session 4B Family-centred care Angie Hamilton LLB BCL Louise Lemieux White BScN RN |
Session 4C Contingency management Melissa Holowaty PhD MD CCFP (AM) |